June 5, 2009

In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High

On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.

At 76 and 75, respectively, AstraZeneca and Johnson & Johnson lead the first-ever review of the pharmaceutical sector by Climate Counts.

Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.

Climate Counts evaluates firms’ commitments in four areas:

  • whether they have measured their carbon footprint
  • if they reduced their impact on global warming
  • if they….

    Register here to join EL Pro. View more PRO content or .

    Environmental Leader's Pro service delivers opportunity-focused, practical insights, data and news for enterprise environmental, energy and sustainability execs.

    25+ page research reports covering an emerging energy, environmental or sustainability technology.

    Daily presentation-ready graphs and spreadsheets on energy, environmental and sustainability data.

    Monthly newsletter focusing on the most important news of the previous 30 days – and the implications for your business.

    Daily policy and regulatory, standards and certifications, and enforcement briefing.

    Latest news on corporate environmental, sustainability and energy initiatives and goals.

    Join now and receive instant access to our archive of research, data, and analysis. New content added daily.

    Subscribe Now!

    Stay Up-to-Date On Environmental Management, Energy & Sustainability News with EL's Free Daily Newsletter

    Reader Comments

    There are no comments for this story.

     

    Advertisers